[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$abcls
Crypto project sees positive social sentiment. Market volatility remains a concern for investors.
About $abcls
A cryptocurrency project.
Insights #
- $abcls mentions hit X which is XXX% higher than it's daily average.
- $abcls engagements hit XXXXX which is XXX% higher than it's daily average.
Engagements: XXXXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXX
1 Week: XXXXX +10,888%
1 Month: XXXXX +110%
1-Year High: XXXXX on 2025-08-09
1-Year Low: X on 2025-06-30
| Social Network | X | |
|---|---|---|
| Engagements | XX | XXXXX |
Mentions: X #
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
1 Month: X no change
1-Year High: X on 2025-08-12
1-Year Low: X on 2025-06-14
| Social Network | X | |
|---|---|---|
| Mentions | X | XX |
Creators: X #
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $abcls in the last XX hours which is up XX% from X in the previous XX hours
Daily Average: X
1 Month: X +100%
1-Year High: X on 2025-08-12
1-Year Low: X on 2025-06-14
The most influential creators that mention $abcls in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Stonkstronaut | X | XXX | X | XX |
Top topics mentioned In the posts about $abcls in the last XX hours
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Hot take on $ABCL's XXX after the disappointing XX% placebo-adjusted remission rate for Sanofi's amlitelimab in its Phase X COAST-1 trial. Both molecules target the early OX40L checkpoint for inflammation in AtD. $SNY's results are encouraging in terms of MoA validation but weren't quite up to the expectations set by Dupixent (27% remission at Week XX in CHRONOS). AbCelleras molecule has an engineered Fc that provides an extended half-life alongside Fc silencing. This could translate to less frequent dosing and more consistent blockade of OX40L potentially resulting in improved remission"
X Link @iHooghvorst 2025-10-22T11:47Z 3354 followers, 5306 engagements
"🚀 $ABCL breakout from descending wedge delivered big gains and another wedge is forming below the first target Solid growth story with Phase X trials & $840M cash. Long-term hold 📈 #StockMarket Visual: Imagine a sleek chart showing $ABCLs price spiking post-breakout now consolidating in a tight wedge. Want me to generate it"
X Link @bullrunbyte 2025-10-14T21:19Z XXX followers, XXX engagements
"$ABCLs Abdera Partnership Just Got Even More Exciting"
Reddit Link @Stonkstronaut 2025-09-09T17:01Z X followers, XXX engagements
"Why Sanofis amlitelimab stumble could be bullish for $ABCLs ABCL575"
Reddit Link @Stonkstronaut 2025-09-04T15:08Z X followers, XXX engagements